$RLYB
Rallybio Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Rallybio Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RLYB down today? It is at $15.75 (-0.32%), and our scanner flagged it 41 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RLYB spikes, and full due diligence on RLYB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RLYB 41 times in the last 30 days. Create a free account to track $RLYB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how RLYB traded in the last session, Friday (last price and move above). Our scanner fired 14 unusual-volume and momentum alerts on RLYB on Friday, peaking at 18.8x its normal volume. Trading was halted for volatility on Friday, which usually marks a fast, sharp move.
Likely catalystMerger / acquisition agreementPrice $0.0001/shareReverse split plannedStatus pending stockholder approval, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Merger prospectus on file: the company is issuing new shares to pay for an acquisition
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hunt Ronald Director | Other | 14K 0.3% of company | added 97% | 29K | $64K at $4.45 | Nov 4, 26 |
Mackay Martin Director | Other | 33K 0.6% of company | added 36% | 125K | $79K at $2.38 | Nov 4, 26 |
Lieber Jonathan I Officer | Other | 7K 0.1% of company | added 19% | 44K | $106K at $14.88 | Nov 2, 26 |
Hunt Ronald Director | Other | 15K 0.3% of company | n/a | 15K | $35K at $2.38 | Oct 29, 26 |
Lieber Jonathan I Officer | Other | 21K 0.4% of company | added 100% | 37K | $131K at $6.08 | Oct 29, 26 |
Nash Christine A Director | Other | 4K 0.06% of company | n/a | 4K | $8K at $2.38 | Oct 28, 26 |
Lieber Jonathan I Officer | Sold (automatic/other) | -599 0.01% of company | sold 3.7% | 16K | $10K at $16.04 | Oct 27, 26 |
Uden Stephen Officer | Other | 33K 0.6% of company | added 29% | 149K | $202K at $6.08 | Oct 27, 26 |
Chung Wendy Director | Other | 2K 0.04% of company | added 58% | 6K | $32K at $15.28 | Oct 26, 26 |
Lieber Jonathan I Officer | Acquired (grant/award) | +3K 0.04% of company | added 18% | 16K | n/a | Oct 26, 26 |
Boudreau Helen M Director | Other | 2K 0.04% of company | added 32% | 9K | $32K at $15.28 | Oct 16, 26 |
Soteropoulos Paula Director | Other | 4K 0.06% of company | added 100% | 7K | $8K at $2.38 | Oct 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how RLYB traded in the last session, Friday (last price and move above). Our scanner fired 14 unusual-volume and momentum alerts on RLYB on Friday, peaking at 18.8x its normal volume. Trading was halted for volatility on Friday, which usually marks a fast, sharp move.
RLYB last traded at $15.75, down 0.32% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RLYB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLYB 41 times in the last 30 days.
RLYB (Rallybio Corporation Common Stock) trades on XNAS, with a market cap of about $87M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLYB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
RLYB is scheduled to reverse split 1-for-2 on Nov 23, 2026: every 2 shares become 1, and the price adjusts by the same ratio, so a holding is worth the same the moment it happens.
Across 698 US reverse splits we measured, the median stock was 32.4% lower three months after the split, and 77% were lower. What happens after a reverse split
From our split records and daily closes. Every recent split. Not investment advice.
$RLYB discussion
Sign in to ask a question or join the discussion.